MRAR - Maladies rares

THERAPIE MOLECULAIRE POUR LE TRAITEMENT DE GLYCOSPHINGOLIPIDOSES – IMINOGLYCODRUGS

Project coordination

Olivier MARTIN (Université)

The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.

Partner

Help of the ANR 356,518 euros
Beginning and duration of the scientific project: - 36 Months

Useful links

Explorez notre base de projets financés

 

 

ANR makes available its datasets on funded projects, click here to find more.

Sign up for the latest news:
Subscribe to our newsletter